397 related articles for article (PubMed ID: 25262409)
1. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
[TBL] [Abstract][Full Text] [Related]
2. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
Schöttler S; Landfester K; Mailänder V
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release from nanocarriers: a review.
Natarajan JV; Nugraha C; Ng XW; Venkatraman S
J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
Sharifi S; Caracciolo G; Mahmoudi M
Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
[TBL] [Abstract][Full Text] [Related]
7. Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation.
Chen H; Woods A; Forbes B; Jones S
Int J Pharm; 2016 Sep; 511(2):1033-41. PubMed ID: 27506512
[TBL] [Abstract][Full Text] [Related]
8. Intracellular delivery of proteins by nanocarriers.
Ray M; Lee YW; Scaletti F; Yu R; Rotello VM
Nanomedicine (Lond); 2017 Apr; 12(8):941-952. PubMed ID: 28338410
[TBL] [Abstract][Full Text] [Related]
9. Clickable protein nanocapsules for targeted delivery of recombinant p53 protein.
Zhao M; Liu Y; Hsieh RS; Wang N; Tai W; Joo KI; Wang P; Gu Z; Tang Y
J Am Chem Soc; 2014 Oct; 136(43):15319-25. PubMed ID: 25289975
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
Fleige E; Quadir MA; Haag R
Adv Drug Deliv Rev; 2012 Jun; 64(9):866-84. PubMed ID: 22349241
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive nanocapsules for intracellular protein delivery.
Zhao M; Biswas A; Hu B; Joo KI; Wang P; Gu Z; Tang Y
Biomaterials; 2011 Aug; 32(22):5223-30. PubMed ID: 21514660
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues.
Villegas MR; Baeza A; Vallet-Regí M
ACS Appl Mater Interfaces; 2015 Nov; 7(43):24075-81. PubMed ID: 26461206
[TBL] [Abstract][Full Text] [Related]
13. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems.
Dell'Orco D; Lundqvist M; Linse S; Cedervall T
Nanomedicine (Lond); 2014 May; 9(6):851-8. PubMed ID: 24981650
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria Targeting Non-Isocyanate-Based Polyurethane Nanocapsules for Enzyme-Triggered Drug Release.
Pramanik SK; Sreedharan S; Singh H; Khan M; Tiwari K; Shiras A; Smythe C; Thomas JA; Das A
Bioconjug Chem; 2018 Nov; 29(11):3532-3543. PubMed ID: 30036048
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
Cifuentes-Rius A; de Puig H; Kah JC; Borros S; Hamad-Schifferli K
ACS Nano; 2013 Nov; 7(11):10066-74. PubMed ID: 24128271
[TBL] [Abstract][Full Text] [Related]
17. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona.
Peng Q; Wei XQ; Yang Q; Zhang S; Zhang T; Shao XR; Cai XX; Zhang ZR; Lin YF
Nanomedicine (Lond); 2015 Jan; 10(2):205-14. PubMed ID: 25600966
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D
Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
[TBL] [Abstract][Full Text] [Related]
19. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
20. Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules.
Sánchez-Moreno P; Buzón P; Boulaiz H; Peula-García JM; Ortega-Vinuesa JL; Luque I; Salvati A; Marchal JA
Biomaterials; 2015 Aug; 61():266-78. PubMed ID: 26005765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
